A recent randomized, double-blind, placebo-controlled clinical trial demonstrates that daily oral supplementation of nicotinamide (NAM) and pyridoxine (PN) significantly enhances muscle stem cell (MuSC) activity and accelerates structural repair following acute muscle injury in humans. Maintaining skeletal muscle integrity is a primary determinant of healthspan, yet endogenous regenerative capacity is frequently outpaced by age-related wasting (sarcopenia), cachexia, and severe physical trauma. Currently, no targeted clinical therapeutics exist to directly upregulate the MuSC-mediated repair sequence.
In this trial, healthy young men were subjected to a highly damaging neuromuscular electrical stimulation (NMES) protocol combined with eccentric contractions to induce localized myofiber necrosis. Participants were supplemented daily with 714 mg of NAM and 19 mg of PN, or a placebo, for nine days. The intervention was well-tolerated and elevated systemic concentrations of NAM, PN, and pyridoxal 5’-phosphate (PLP, the bioactive form of PN).
Histological analysis of muscle biopsies acquired eight days post-injury revealed a robust regenerative advantage in the supplemented cohort. NAM/PN treatment did not alter the quiescent MuSC pool, but it significantly increased the density of activated Pax7+ cells by 29%, MyoD+ proliferating progenitors by 67%, and terminally differentiating myogenin+ cells by 34%, relative to placebo. Consequently, the proportion of regenerating myofibers expressing embryonic myosin heavy chain (eMyHC) was elevated by 37%.
These findings provide compelling in vivo human evidence that the synergistic application of specific B-vitamin vitamers can bypass standard metabolic rate-limiters to force-multiply the myogenic program. While further data is required to confirm functional strength recovery and efficacy in aged demographics, this intervention presents a highly actionable, low-risk nutritional strategy for accelerating skeletal muscle repair and potentially mitigating pathological muscle wasting.
Source:
- Open Access Paper: Nicotinamide and Pyridoxine Supplementation Enhances Muscle Stem Cell Activity and Muscle Regeneration in Humans: A Randomized Placebo-Controlled Clinical Trial of High Force Eccentric Contraction Recovery in Healthy Young Men
- Institution: This research was conducted by the Institute of Sports Medicine Copenhagen at Copenhagen University Hospital, Denmark, in collaboration with the Nestlé Institute of Health Sciences, Switzerland.
- Journal: published in Advanced Science.
- Impact Evaluation: The impact score of this journal is 14.3, evaluated against a typical high-end range of 0–60+ for top general science, therefore this is a High impact journal.